This country profile provides an overview of the United Republic of Tanzania’s progress in reaching those in need of mass NTD treatment based on 2017 data.

*This includes all countries in Africa that are endemic for at least one of the five NTDs

Download country profile

Treatment coverage

Elephantiasis
84%
Blinding trachoma
82%
Intestinal worms
94%
Bilharzia
100%
River blindness
81%
23.34 million people received treatment in Tanzania in 2017 3.37 million people did not receive treatment in Tanzania in 2017

Priorities for progress in the United Republic of Tanzania

  • Tanzania is making good progress.
  • It should continue to maintain high coverage rates, which should see a number of diseases achieve elimination.
  • Support the Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN) established by WHO AFRO region for the elimination of these five diseases.

Elephantiasis

Treatment coverage decreased from 86% in 2016 to 84% in 2017.

People needing treatment
9.95m
People receiving treatment
8.83m

Blinding trachoma

Treatment coverage slightly increased from 7% in 2016 to 82% in 2017.

People needing treatment
3.22m
People receiving treatment
2.65m

Intestinal worms

Treatment increased decreased from 55% in 2016 to 94% in 2017.

Pre-sch and school-aged children needing treatment
17.64m
Pre-school and school-aged children receiving treatment
16.52m

Bilharzia

Treatment coverage increased from 98% in 2016 to 100% in 2017.

School-aged children needing treatment
6.92m
School-aged children receiving treatment
6.92m

River blindness

Treatment coverage increased from 71% in 2016 to 81% in 2017.

People needing treatment
6.22m
People receiving treatment
5.06m

The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Tanzania.